Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata
- 1 May 1997
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 67 (5), 837-841
- https://doi.org/10.1016/s0015-0282(97)81394-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Histopathologic Findings in 107 Uterine Leiomyomas Treated with Leuprolide Acetate Compared with 126 ControlsThe American Journal of Surgical Pathology, 1996
- Leuprolide acetate treatment and myoma arterial sizeObstetrics & Gynecology, 1995
- Morphological Changes in Uterine Leiomyomas Treated by GnRH Agonist GoserelinInternational Journal of Gynecological Pathology, 1995
- Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese womenFertility and Sterility, 1992
- The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one monthEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1992
- Treatment of uterine fibroids: Current findings withgonadotropin-releasing hormone agonistsAmerican Journal of Obstetrics and Gynecology, 1992
- Symptom-Free Interval After Triptorelin Treatment of Uterine Fibroids: Long-Term ResultsGynecological Endocrinology, 1992
- Histopathological changes in leiomyomata treated with leuprolide acetateFertility and Sterility, 1990
- Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: The estrogen threshold hypothesisAmerican Journal of Obstetrics and Gynecology, 1990
- A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomataFertility and Sterility, 1989